Notice of competing interests
=============================


The competing interests statements that were not available when the July 2002 issue of the *Journal of Psychiatry & Neuroscience* went to press appear below.

For: Tranter R, O’Donovan C, Chandarana P, Kennedy S. Prevalence and outcome of partial remission in depression. *J Psychiatry Neurosci* 2002;27(4):241–7.

Dr. O’Donovan has received consultancy fees from Eli Lilly, an honorarium for participating in the development of the article from Wyeth-Ayerst and speaker fees from Eli Lilly and GlaxoSmithKline.

For: Segal Z, Vincent P, Levitt A. Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression. *J Psychiatry Neurosci* 2002;27(4):281–90.

Dr. Vincent has served on advisory boards for Organon and Eli Lilly and has received speaker fees from Pharmacia, Organon and Eli Lilly.

Dr. Levitt has received consultancy fees from Eli Lilly and Janssen-Ortho; speaker fees from Wyeth-Ayerst, Lundbeck, Eli Lilly and Janssen-Ortho; and travel assistance from Wyeth-Ayerst.